Pinned Tweet
🎉 Exciting news!
#Neuroprotection has received its first Journal Impact Factor: 4.1
A sincere thank you to our authors, reviewers, editors, editorial board members, and readers for making this milestone possible
Together, we are advancing neuroprotection from bench to bedside
How may chronic high-altitude exposure worsen intracerebral hemorrhage?
A new #Neuroprotection Review explores vascular–immune–neuronal dysfunction, hypoxia-inducible factor signaling, oxidative stress & neuroinflammation in this context.
doi.org/10.1002/nep3.70059
Neuroprotection retweeted
"Target Expansion Criteria" for #ICH patients who may benefit from acute therapies in late window. @GreenJournal @NawabiJawed @fmazzacane01 @Libero131087 @RaffaeleOrnello @giovmerl @matpaolucci @m_paciaroni @Simona_Sacco_ @MicheleRomoli @ZiniAndrea @QiLiMD
neurology.org/doi/10.1212/WN…
🧠 Can efgartigimod help treat autoimmune encephalitis?
In a prospective study of 18 patients with anti-NMDAR or anti-LGI1 encephalitis, clinical scores improved & treatment was well tolerated. PET/MRI findings were promising in a subset #neuroprotection
doi.org/10.1002/nep3.70063
🧠 Could antimicrobial drugs be repurposed for #neuroprotection?
A new Neuroprotection Review explores how tetracyclines, macrolides, antimalarials & other agents may modulate neuroinflammation, oxidative stress and the gut-brain axis.
doi.org/10.1002/nep3.70042
Can #neuromodulation protect the brain after ischemic #stroke?
A #Neuroprotection systematic review & meta-analysis of 30 animal studies (2,347 reported animals) found reduced infarct volume and improved neurological outcomes.
doi.org/10.1002/nep3.70056
How will China’s ischemic #stroke burden change by 2050?
A new study using GBD 2021 data projects continued growth in incidence, with population aging becoming the dominant driver. By 2050: 3.68M incident cases & 1.50M deaths projected.
doi.org/10.1002/nep3.70060
#Neuroprotection
🧠 Our latest Editorial by Piotr Walczak, Shen Li, Xunming Ji & Johannes Boltze explores the diverse contributions in Vol. 4, Issue 3 - from stroke, epilepsy & AD to TBI, #neuroregeneration, cell tracking & the history of glial biology.
doi.org/10.1002/nep3.70058
#Neuroprotection
Can platelet function testing improve personalized antiplatelet therapy after cerebral infarction? [1/2]
doi.org/10.1002/nep3.70057
#Neuroprotection #Stroke
Could serum elements help identify #Alzheimer’s disease?
This new article combines profiles of 20 serum elements with machine learning. A random forest model achieved 88% accuracy for AD identification, with exploratory prediction of MMSE & MoCA scores.
doi.org/10.1002/nep3.70054
How is the global burden of #epilepsy changing?
Our latest review examines GBD 2021 data, highlighting epidemiological transitions, major regional & urban-rural inequalities, healthcare gaps, & priorities for integrated epilepsy governance.
doi.org/10.1002/nep3.70053
Neuroprotection retweeted
We are pleased to announce that the 2025 CiteScore of Neuroprotection reaches 3.3!🎉
onlinelibrary.wiley.com/jour…
#citescore #scopus #Neuprotection
Neuroprotection retweeted
How limb laterality might impact Remote Ischemic Conditioning (RIC) in stroke. Practical clinical choices (which arm to use?) may actually have biological rationale via somatosensory modulation. Preclinical & clinical research must catch up! 🧠🩺onlinelibrary.wiley.com/doi/…
🧠 A forgotten architect of glial biology
A new Commentary in #Neuroprotection revisits the work of Nicolás Achúcarro (1880–1918), whose pioneering histological studies helped establish #glia as dynamic participants in brain pathology. [1/2]
📖 doi.org/10.1002/nep3.70051
His observations anticipated concepts central to modern #neuroscience including #neuroinflammation, glial metabolism, neurovascular interactions and #neuroprotection.
More than a century later, his legacy remains highly relevant.
#Glia
Neuroprotection retweeted
Fascinating new research from @NeuroPJournal. Enjoy reading.
#Neuroprotection
📢 #Neuroprotection Volume 4 Issue 3 is live! — all articles #OpenAccess.
👉 onlinelibrary.wiley.com/toc/…
@NeuroPJournal @ZilleMarietta @Chenhsbbb @agetliang #stroke #neurodegeneration
🧠 New in #Neuroprotection: #TBI severity shapes the #neuroimmune response
A graded mouse TBI model shows distinct severity-dependent responses. [1/2]
📖 doi.org/10.1002/nep3.70044
#Neuroinflammation #Microglia #Astrocytes
🔹 Mild TBI → reparative microglial/astrocytic phenotypes
🔹 Severe TBI → sustained pro-inflammatory M1/A1 activation
🔹 IL-6 &UCHL1 rise early after severe injury
🔹 Minocycline attenuates #neuroinflammation & improves motor recovery
#Neuroprotection #TBI #Microglia #Astrocyte
🌙 New review in #Neuroprotection: Circadian rhythms and chronotherapy in Alzheimer’s disease [1/2]
📖 doi.org/10.1002/nep3.70046
#Alzheimers #CircadianRhythms #Chronotherapy #Neuroscience
Circadian dysfunction may be an early, modifiable contributor to AD.
This review explores clock genes, #neuroinflammation, #proteostasis, #biomarkers & emerging chronotherapeutic strategies (light therapy, melatonin, time-restricted feeding, circadian-aligned drug delivery).










